Search

Author/Creator Khadem Azarian, Shahin

1. A randomized clinical trial for the assessment of the efficacy and safety of guluronic acid (G2013) in patients with rheumatoid arthritis. (2nd January 2019)

Authors:
Khadem Azarian, Shahin; Akhlaghi, Maassoumeh; Mahmoudi, Mahdi; Mostafaei, Shayan; Jamshidi, Ahmad Reza; Nazeri, Sepideh; Mirshafiey, Abbas
Journal:
Immunopharmacology and immunotoxicology
Issue:
Volume 41:Number 1(2019)
Page Start:
95
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Effects of guluronic acid, as a new NSAID with immunomodulatory properties on IL-17, RORγt, IL-4 and GATA-3 gene expression in rheumatoid arthritis patients. (2nd January 2020)

Authors:
Khadem Azarian, Shahin; Jafarnezhad-Ansariha, Fahimeh; Nazeri, Sepideh; Azizi, Gholamreza; Aghazadeh, Zahra; Hosseinzadeh, Elham; Mirshafiey, Abbas
Journal:
Immunopharmacology and immunotoxicology
Issue:
Volume 42:Number 1(2020)
Page Start:
22
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Preclinical and pharmacotoxicology evaluation of α-l-guluronic acid (G2013) as a non-steroidal anti-inflammatory drug with immunomodulatory property. (4th March 2017)

Authors:
Nazeri, Sepideh; Khadem Azarian, Shahin; Fattahi, Mohammad Javad; Sedaghat, Reza; Tofighi Zavareh, Farzaneh; Aghazadeh, Zahra; Abdollahi, Mohammad; Mirshafiey, Abbas
Journal:
Immunopharmacology and immunotoxicology
Issue:
Volume 39:Number 2(2017:Apr.)
Page Start:
59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗